Browse by author
Lookup NU author(s): Dr Sebastian Sethe
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Recent policy developments in the United States and Europe have created new regulatory regimes for advanced and complex treatments such as cell therapies, tissue engineering, and gene therapies that are of particular relevance for regenerative medicine. Where these new legal rules operate as a mere extension of existing regimes, they risk stifling innovation in these areas of life extension technology. © 2010 Mary Ann Liebert, Inc.
Author(s): Sethe S
Publication type: Note
Publication status: Published
Journal: Rejuvenation Research
Print publication date: 01/04/2010
ISSN (print): 1549-1684
ISSN (electronic): 1557-8577
PubMed id: 20462386